Description
Creative Biolabs has developed several immune checkpoint stable cell Lines expressing the most popular immune checkpoints to accelerate clients' immunotherapy discovery and clinical translation. The TRAC (T-Cell Receptor Alpha Constant) and TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains have both been genetically removed by CRISPR/Cas9 genome editing from recombinant Jurkat cells constitutively expressing the firefly luciferase gene under the control of NFAT response elements. Which can be used in binding assays and functional assay.
Features
Stable cell lines for increased reliability and reproducibility;
Protein expression at the cell surface validated by FACS or WB;
Applications
TCR Knockout NFAT-Luciferase Reporter Jurkat Recombinant cells can be used as a control for generating CAR-T cells, as well as for determining CAR-T specific cell killing.
Organism
Human
Strain Name
Jurkat
Common Name
TCR-/- & NFAT-Luciferase Reporter

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.